Literature DB >> 17485964

Seven decades of progress.

Marvin Moser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485964      PMCID: PMC8109915          DOI: 10.1111/j.1524-6175.2007.06304.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  15 in total

1.  I. Critical evaluation of drug therapy of hypertension.

Authors:  M MOSER; T W MATTINGLY
Journal:  Postgrad Med       Date:  1955-05       Impact factor: 3.840

2.  Chlorothiazide as an adjunct in the treatment of essential hypertension.

Authors:  M MOSER; A I MACAULAY
Journal:  Am J Cardiol       Date:  1959-02       Impact factor: 2.778

3.  Effect of pentaquine in patients with hypertension.

Authors:  E D FREIS; R W WILKINS
Journal:  Proc Soc Exp Biol Med       Date:  1947-04

Review 4.  From JNC I to JNC 7--what have we learned?

Authors:  Marvin Moser
Journal:  Prog Cardiovasc Dis       Date:  2006 Mar-Apr       Impact factor: 8.194

5.  Pyrogens in the treatment of malignant hypertension.

Authors:  I H PAGE; R D TAYLOR
Journal:  Mod Concepts Cardiovasc Dis       Date:  1949-10

6.  Clinical notes on the illness and death of President Franklin D. Roosevelt.

Authors:  H G Bruenn
Journal:  Ann Intern Med       Date:  1970-04       Impact factor: 25.391

7.  Blood pressure and risk of coronary heart disease: the Framingham study.

Authors:  W B Kannel; M J Schwartz; P M McNamara
Journal:  Dis Chest       Date:  1969-07

8.  Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.

Authors:  M Moser; P R Hebert
Journal:  J Am Coll Cardiol       Date:  1996-04       Impact factor: 24.094

9.  Hypertension icons: Henry R. Black's interview with Marvin Moser, MD.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-01       Impact factor: 3.738

10.  Hypertension treatment--a success study.

Authors:  Marvin Moser
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.